The world is moving ever closer to a generation that might actually see something resembling X-Men's Xavier's hovering wheelchair. The Whill Model M is a motorized wheelchair that not only looks very futuristic, but acts like it as well. Recently approved by the Food and Drug Administration in the United States, the Whill Model M will be able to be prescribed by physicians as a medical device and covered by insurance.
The predecessor to the Type-A, which it didn’t seek FDA approval for, the Whill Model M boasts "a patented wheel that allows users to make tighter turns in all directions, increasing their mobility and allowing them to maneuver easily on rough or sloping surfaces," reports Tech Crunch. This could make a vast difference in the limited movement of wheelchair-bound patients.
Key Themes Behind This Trend
- Futuristic Wheelchairs
- Opportunity for companies to innovate and create more advanced motorized wheelchairs with increased mobility features.
- Medical Device Revolution
- With the FDA approval of the Whill Model M, there is an opportunity for more medical devices to be developed and prescribed as alternatives to traditional medical equipment.
- Improved Mobility Technology
- Advancements in mobility technology will create a more accessible world for those with disabilities, allowing them to maneuver on rough or sloping surfaces with greater ease and confidence.
Where This Applies
- Healthcare Technology
- Innovators in healthcare technology could build upon the success of the Whill Model M to create more advanced medical devices that enhance patients' quality of life.
- Mobility Aids
- Companies that specialize in mobility aids like wheelchairs, walkers, and crutches can incorporate the patented technology of the Whill Model M into their products to make them more advanced and desirable to consumers.
- Insurance
- The increase in FDA-approved medical devices like the Whill Model M creates opportunities for insurance companies to expand coverage to non-traditional medical equipment to improve patients' quality of life and lower costs.
